Market Tracker

06/23 5:16pm ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

9.30
Delayed Data
As of Jun 23
 +0.10 / +1.09%
Today’s Change
2.65
Today|||52-Week Range
9.45
+204.92%
Year-to-Date
Shark Bites: Move Along, No Volatility to See Here
Jun 22 / TheStreet.com - Paid Partner Content
3 Biotech Stocks That More than Doubled Year to Date
Jun 19 / Zacks.com - Paid Partner Content
Biotech Movers: Sangamo, Epizyme, Revance
Jun 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close9.20
Today’s open9.35
Day’s range8.95 - 9.45
Volume1,740,043
Average volume (3 months)1,231,493
Market cap$760.3M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)-2.94%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book4.84

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+0.28+1.42%
NDRMNeuroderm Ltd+0.75+2.60%
EDITEditas Medicine Inc+0.41+2.34%
CHRSCoherus BioSciences ...-0.15-0.95%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts